AI in anesthesia is still in its early stages, but exciting developments are on the horizon that could further transform the practice. One significant trend is the increasing sophistication of AI-driven decision-support tools. These tools are evolving from basic monitoring aids to advanced systems capable of offering real-time, actionable recommendations during complex surgeries. For example, AI algorithms are being developed to assist with fluid management, providing precise recommendations on fluid administration based on continuous hemodynamic monitoring and predictive modeling; assisted fluid management software that suggests boluses from the patient's stroke volume response has been commercially available in the United States since 2020.
In addition to decision-support tools, AI is making waves in medical education and simulation. AI-powered simulators can replicate complex clinical scenarios, allowing anesthesia providers to practice their skills in a safe, controlled environment. These systems can present providers with rare or challenging cases, helping them prepare for situations that may be difficult to manage in real life. Furthermore, AI-driven educational platforms can personalize learning experiences by adapting to the provider’s knowledge level and focusing on areas that require improvement.
The future of AI in anesthesia may also include robotic-assisted anesthesia. Research prototypes already exist: a closed-loop system that simultaneously controlled hypnosis, analgesia, and neuromuscular blockade outperformed manual control in a randomized trial (Hemmerling et al., 2013), and the same group reported the first robot-assisted tracheal intubations in humans (Hemmerling et al., 2012). As robotic surgery becomes more prevalent, AI may play an integral role in optimizing anesthesia delivery to match the precision of robotic surgical systems. This could involve real-time adjustments to anesthetic depth, ventilation, and hemodynamic management based on the specific demands of robotic procedures.
Looking ahead, there is even the potential for fully autonomous anesthesia systems for routine, low-risk surgeries. While anesthesia providers will remain indispensable for complex cases, AI systems may be capable of managing anesthesia autonomously in select cases, reducing provider workload and improving efficiency. However, this will require significant advancements in both AI technology and regulatory oversight to ensure that these systems are safe, reliable, and effective. The only automated sedation device to reach the United States market, a computer-assisted propofol sedation system for endoscopy approved by the FDA in 2013, was withdrawn by its manufacturer in 2016 after limited adoption, a reminder that regulatory approval is not the only hurdle these systems face.
